Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$216.6K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Mar 2 | AGIO | Agios Pharmaceuticals,… | MEXER◷◆ | 2,450 | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | AGIO | Agios Pharmaceuticals,… | MEXER◷◆ | 2,350 | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | AGIO | Agios Pharmaceuticals,… | SSELL◷ | 798 | $28.96 | $23.1K | -11.5% | Open the original filing on SEC.gov |
| Mar 2 | AGIO | Agios Pharmaceuticals,… | MEXER◷ | 2,695 | — | — | +63.5% | Open the original filing on SEC.gov |
| Mar 2 | AGIO | Agios Pharmaceuticals,… | SSELL◷ | 727 | $28.96 | $21.1K | -14.6% | Open the original filing on SEC.gov |
| Mar 2 | AGIO | Agios Pharmaceuticals,… | MEXER◷ | 2,450 | — | — | +97.2% | Open the original filing on SEC.gov |
| Mar 2 | AGIO | Agios Pharmaceuticals,… | SSELL◷ | 698 | $28.96 | $20.2K | -21.2% | Open the original filing on SEC.gov |
| Mar 2 | AGIO | Agios Pharmaceuticals,… | MEXER◷ | 2,350 | — | — | +249.2% | Open the original filing on SEC.gov |
| Mar 1 | AGIO | Agios Pharmaceuticals,… | AGRANT◷◆ | 8,452 | — | — | — | Open the original filing on SEC.gov |